EGFR and lung adenocarcinoma: This result aligns with the findings of previous studies that investigated the prediction of epidermal growth factor receptor (EGFR) mutations[32], the invasiveness of lung adenocarcinoma[31], and microvascular invasion in hepatocellular carcinoma[33].